Launched at Penn’s UPstart incubator, Haddonfield’s Linnaeus Therapeutics is in the early stages of clinical trials for an anti-cancer drug.
Launched at Penn’s UPstart incubator, Haddonfield’s Linnaeus Therapeutics is in the early stages of clinical trials for an anti-cancer drug.